Vivelle-Dot is a small, prescription estrogen patch that delivers estradiol through your skin to treat menopause symptoms and help prevent osteoporosis. It belongs to a class of medications called hormone replacement therapy, and it works by steadily releasing a low dose of estradiol (the most potent natural form of estrogen) into your bloodstream over several days. The patch is replaced twice a week.
How Vivelle-Dot Works
As women approach and pass through menopause, their ovaries produce significantly less estrogen. That drop is what triggers hot flashes, night sweats, vaginal dryness, and the gradual bone loss that can lead to osteoporosis. Vivelle-Dot replaces some of that lost estrogen by absorbing it directly through the skin and into the bloodstream, bypassing the digestive system entirely. This transdermal route avoids the “first pass” through the liver that oral estrogen pills go through, which is one reason some prescribers prefer patches.
Available Doses
Vivelle-Dot comes in five strengths, measured by how much estradiol the patch delivers per day: 0.025 mg, 0.0375 mg, 0.05 mg, 0.075 mg, and 0.1 mg. Most women start at the lowest effective dose, and the prescriber adjusts up if symptoms aren’t adequately controlled. Higher doses are sometimes used specifically for bone loss prevention when lower strengths aren’t sufficient.
How to Apply the Patch
You place Vivelle-Dot on a clean, dry area of your abdomen or buttocks, pressing the adhesive side firmly against the skin. It should not be applied to your breasts. The patch stays on for three to four days before you swap it for a fresh one, totaling two patch changes per week. Many women pick consistent days, like every Sunday and Wednesday, to make the schedule easier to remember.
Rotating the application site matters. Wait at least one week before putting a new patch on the same spot, which helps prevent skin irritation. Avoid placing it where clothing will rub heavily or where it could be pulled off easily. If a patch falls off, you can reapply it or use a new one, then stick with your regular replacement schedule.
What It Treats
Vivelle-Dot is FDA-approved for two primary uses. The first is treating moderate to severe vasomotor symptoms of menopause, the medical term for hot flashes and night sweats. The second is preventing postmenopausal osteoporosis, the thinning of bones that accelerates after estrogen levels fall. For osteoporosis prevention specifically, non-estrogen options are typically considered first, with Vivelle-Dot reserved for women who can’t take or don’t respond to those alternatives.
Women who still have a uterus are prescribed a progestin alongside Vivelle-Dot. Estrogen used alone in someone with a uterus increases the risk of endometrial cancer. Adding a progestin offsets that risk. Women who have had a hysterectomy generally use estrogen alone.
Common Side Effects
The most frequently reported side effects in clinical trials, each occurring in 10% or more of users, include headache, breast tenderness, back pain, depression, and irregular vaginal bleeding or spotting. Upper respiratory symptoms like sinus congestion and sore throat also appeared at similar rates. Many of these side effects are most noticeable in the first few months and often ease as the body adjusts to the hormone.
Skin irritation at the patch site is another common complaint. Redness, itching, or mild rash where the adhesive sits tends to improve with consistent site rotation. If irritation persists or worsens, it may help to switch to a different area of the abdomen or buttocks, or discuss alternatives with your prescriber.
Serious Risks to Know About
Vivelle-Dot carries an FDA boxed warning, the most serious type of safety alert. Estrogen therapy increases the risk of endometrial cancer in women who still have a uterus and are not also taking a progestin. The warning also notes that estrogens, with or without progestins, should not be used to prevent heart disease.
Data from the Women’s Health Initiative, a large long-term study of postmenopausal hormone use, found increased rates of heart attack, stroke, blood clots in the lungs and legs, and invasive breast cancer among women taking oral estrogen combined with a progestin. The general principle from that research is to use the lowest effective dose for the shortest time needed. Your individual risk depends on age, how many years past menopause you are, personal and family medical history, and other factors your prescriber will weigh.
The label also notes that “natural” estrogens like estradiol have not been shown to carry a different risk profile for endometrial cancer compared to synthetic estrogens. The source of the hormone does not change its effect on uterine tissue.
Drug Interactions
Estradiol can affect how your body handles blood sugar, so women taking diabetes medications may notice changes in glucose control after starting or stopping the patch. Periodic monitoring is recommended if you use blood sugar-lowering medications. Certain seizure medications, antibiotics, and herbal supplements like St. John’s wort can also speed up the breakdown of estrogen in the body, potentially making the patch less effective. Let your prescriber know everything you take, including over-the-counter products.
Storage and Disposal
Keep unused patches at room temperature, away from heat and humidity. A bathroom medicine cabinet is not ideal because of shower steam. When you remove a used patch, fold it in half so the sticky sides press together, then dispose of it somewhere children and pets cannot reach. Used patches still contain residual hormone, which can be harmful if a child or animal comes into contact with the adhesive. Unused or expired patches should go to a pharmacy take-back program rather than being flushed.